These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 26041300)
1. Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection. Saunders KO; Wang L; Joyce MG; Yang ZY; Balazs AB; Cheng C; Ko SY; Kong WP; Rudicell RS; Georgiev IS; Duan L; Foulds KE; Donaldson M; Xu L; Schmidt SD; Todd JP; Baltimore D; Roederer M; Haase AT; Kwong PD; Rao SS; Mascola JR; Nabel GJ J Virol; 2015 Aug; 89(16):8334-45. PubMed ID: 26041300 [TBL] [Abstract][Full Text] [Related]
2. Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys. Julg B; Sok D; Schmidt SD; Abbink P; Newman RM; Broge T; Linde C; Nkolola J; Le K; Su D; Torabi J; Pack M; Pegu A; Allen TM; Mascola JR; Burton DR; Barouch DH J Virol; 2017 Oct; 91(20):. PubMed ID: 28768869 [TBL] [Abstract][Full Text] [Related]
3. Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo. Rudicell RS; Kwon YD; Ko SY; Pegu A; Louder MK; Georgiev IS; Wu X; Zhu J; Boyington JC; Chen X; Shi W; Yang ZY; Doria-Rose NA; McKee K; O'Dell S; Schmidt SD; Chuang GY; Druz A; Soto C; Yang Y; Zhang B; Zhou T; Todd JP; Lloyd KE; Eudailey J; Roberts KE; Donald BR; Bailer RT; Ledgerwood J; ; Mullikin JC; Shapiro L; Koup RA; Graham BS; Nason MC; Connors M; Haynes BF; Rao SS; Roederer M; Kwong PD; Mascola JR; Nabel GJ J Virol; 2014 Nov; 88(21):12669-82. PubMed ID: 25142607 [TBL] [Abstract][Full Text] [Related]
4. Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection. Saunders KO; Pegu A; Georgiev IS; Zeng M; Joyce MG; Yang ZY; Ko SY; Chen X; Schmidt SD; Haase AT; Todd JP; Bao S; Kwong PD; Rao SS; Mascola JR; Nabel GJ J Virol; 2015 Jun; 89(11):5895-903. PubMed ID: 25787288 [TBL] [Abstract][Full Text] [Related]
5. Antibody gene transfer with adeno-associated viral vectors as a method for HIV prevention. Brady JM; Baltimore D; Balazs AB Immunol Rev; 2017 Jan; 275(1):324-333. PubMed ID: 28133808 [TBL] [Abstract][Full Text] [Related]
6. Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques. Xu L; Pegu A; Rao E; Doria-Rose N; Beninga J; McKee K; Lord DM; Wei RR; Deng G; Louder M; Schmidt SD; Mankoff Z; Wu L; Asokan M; Beil C; Lange C; Leuschner WD; Kruip J; Sendak R; Kwon YD; Zhou T; Chen X; Bailer RT; Wang K; Choe M; Tartaglia LJ; Barouch DH; O'Dell S; Todd JP; Burton DR; Roederer M; Connors M; Koup RA; Kwong PD; Yang ZY; Mascola JR; Nabel GJ Science; 2017 Oct; 358(6359):85-90. PubMed ID: 28931639 [TBL] [Abstract][Full Text] [Related]
7. Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection. Parsons MS; Le Grand R; Kent SJ Viruses; 2018 Jun; 10(6):. PubMed ID: 29912167 [TBL] [Abstract][Full Text] [Related]
8. Enhanced neonatal Fc receptor function improves protection against primate SHIV infection. Ko SY; Pegu A; Rudicell RS; Yang ZY; Joyce MG; Chen X; Wang K; Bao S; Kraemer TD; Rath T; Zeng M; Schmidt SD; Todd JP; Penzak SR; Saunders KO; Nason MC; Haase AT; Rao SS; Blumberg RS; Mascola JR; Nabel GJ Nature; 2014 Oct; 514(7524):642-5. PubMed ID: 25119033 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and immunogenicity of broadly neutralizing HIV monoclonal antibodies in macaques. Rosenberg Y; Sack M; Montefiori D; Labranche C; Lewis M; Urban L; Mao L; Fischer R; Jiang X PLoS One; 2015; 10(3):e0120451. PubMed ID: 25807114 [TBL] [Abstract][Full Text] [Related]
10. Vector-Mediated In Vivo Antibody Expression. Schnepp BC; Johnson PR Microbiol Spectr; 2014 Aug; 2(4):AID-0016-2014. PubMed ID: 26104192 [TBL] [Abstract][Full Text] [Related]
11. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif. Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171 [TBL] [Abstract][Full Text] [Related]
12. Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection. Derby NR; Kraft Z; Kan E; Crooks ET; Barnett SW; Srivastava IK; Binley JM; Stamatatos L J Virol; 2006 Sep; 80(17):8745-62. PubMed ID: 16912322 [TBL] [Abstract][Full Text] [Related]
13. Report of the Cent Gardes HIV Vaccine Conference: The B-cell Response to HIV. Part 1: Broadly Neutralizing Antibodies Fondation Mérieux Conference Center, Veyrier du Lac, France, 5-7 November 2012. Girard MP; Picot V; Longuet C; Nabel GJ Vaccine; 2013 Jun; 31(29):2979-83. PubMed ID: 23499518 [TBL] [Abstract][Full Text] [Related]
14. Expression of HIV-1 broadly neutralizing antibodies mediated by recombinant adeno-associated virus 8 in vitro and in vivo. Yu Y; Fu L; Jiang X; Guan S; Kuai Z; Kong W; Shi Y; Shan Y Mol Immunol; 2016 Dec; 80():68-77. PubMed ID: 27835755 [TBL] [Abstract][Full Text] [Related]
15. Engineered Expression of Broadly Neutralizing Antibodies Against Human Immunodeficiency Virus. Ahmad M; Ahmed OM; Schnepp B; Johnson PR Annu Rev Virol; 2017 Sep; 4(1):491-510. PubMed ID: 28645240 [TBL] [Abstract][Full Text] [Related]
16. Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins. Mascola JR; Sambor A; Beaudry K; Santra S; Welcher B; Louder MK; Vancott TC; Huang Y; Chakrabarti BK; Kong WP; Yang ZY; Xu L; Montefiori DC; Nabel GJ; Letvin NL J Virol; 2005 Jan; 79(2):771-9. PubMed ID: 15613305 [TBL] [Abstract][Full Text] [Related]
17. Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants. Klein F; Nogueira L; Nishimura Y; Phad G; West AP; Halper-Stromberg A; Horwitz JA; Gazumyan A; Liu C; Eisenreich TR; Lehmann C; Fätkenheuer G; Williams C; Shingai M; Martin MA; Bjorkman PJ; Seaman MS; Zolla-Pazner S; Karlsson Hedestam GB; Nussenzweig MC J Exp Med; 2014 Nov; 211(12):2361-72. PubMed ID: 25385756 [TBL] [Abstract][Full Text] [Related]
18. Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope. Letvin NL; Robinson S; Rohne D; Axthelm MK; Fanton JW; Bilska M; Palker TJ; Liao HX; Haynes BF; Montefiori DC J Virol; 2001 May; 75(9):4165-75. PubMed ID: 11287566 [TBL] [Abstract][Full Text] [Related]
19. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection. Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828 [TBL] [Abstract][Full Text] [Related]